Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NCF1 | P14598 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6250335 | 0.88 | IGF1R (0.51) | IGF1RCYP3A4CYP2C9CYP2C19AR | |
| SCHEMBL6175292 | 0.87 | IGF1R (0.65) | IGF1RAR | |
| SCHEMBL6171503 | 0.87 | IGF1R (0.65) | IGF1RAR | |
| SCHEMBL6173279 | 0.86 | IGF1R (0.50) | IGF1RCYP3A4CYP2C9CYP2C19AR | |
| SCHEMBL6172290 | 0.85 | IGF1R (0.45) | IGF1RROCK2MTNR1AMTNR1B | |
| SCHEMBL6174186 | 0.84 | IGF1R (0.51) | IGF1RCYP3A4GAACYP2C9CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL17558459 | 0.83 | IGF1R (0.60) | IGF1RARLMNA | |
| Trifluoroacetic Acid SCHEMBL17558350 | 0.83 | IGF1R (0.60) | IGF1RARLMNA | |
| SCHEMBL6176094 | 0.82 | IGF1R (0.49) | IGF1RMAPTCYP3A4GAACYP2C9 | |
| SCHEMBL6172546 | 0.82 | IGF1R (0.49) | IGF1RMAPTCYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |